/CRLBF

CRLBF Stock - Cresco Labs Inc.

Q: What is the analyst price target for CRLBF?

Analyst price target information is not currently available for CRLBF.

Q: What is CRLBF's market cap?

Market capitalization information is not currently available for CRLBF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$1.30+8.33%

+$0.10 (+8.33%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+323.1%upside

Target: $5.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CRLBF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.73

52W High$2.30

52W Low$0.43

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$724.34M	$770.88M	$842.68M	$821.68M	$476.25M
Gross Profit	$364.45M	$329.89M	$407.01M	$406.35M	$206.70M
Gross Margin	50.3%	42.8%	48.3%	49.5%	43.4%
Operating Income	$107.29M	$-87,823,000	$-84,295,000	$-217,351,000	$-23,462,000
Net Income	$-74,438,000	$-175,522,000	$-212,047,000	$-319,597,000	$-102,157,000
Net Margin	-10.3%	-22.8%	-25.2%	-38.9%	-21.5%
EPS	$-0.22	$-0.54	$-0.71	$-1.22	$-0.49

Company Overview

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

1 Bullish0 Neutral/Bearish

Price Targets

No price targets available

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
December 20th 2022	Cowen	Downgrade	Market Perform	-
October 28th 2022	BTIG Research	Resumed	Buy	-

Earnings History & Surprises

CRLBF

Beat Rate

12%

Last 17 quarters

Avg Surprise

-194.7%

EPS vs Estimate

Beats / Misses

2/13

2 met exactly

Latest EPS

$-0.05

Q4 2025

EPS Surprise History

Q1 24

+150.0%

$0.01vs$-0.02

Q2 24

-4.8%

$-0.02vs$-0.02

Q3 24

-1500.0%

$-0.16vs$-0.01

Q4 24

-474.7%

$-0.02vs$-0.00

Q1 25

0.0%

$-0.01vs$-0.01

Q2 25

-33.3%

$-0.04vs$-0.03

Q3 25

-25.0%

$-0.05vs$-0.04

Q4 25

-66.7%

$-0.05vs$-0.03

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 28, 2026	—	—	—	—
Q1 2026	Mar 13, 2026	$-0.03	—	—	—
Q4 2025	Nov 7, 2025	$-0.03	$-0.05	-66.7%	✗ MISS
Q3 2025	Aug 7, 2025	$-0.04	$-0.05	-25.0%	✗ MISS
Q2 2025	May 30, 2025	$-0.03	$-0.04	-33.3%	✗ MISS
Q1 2025	Mar 14, 2025	$-0.01	$-0.01	0.0%	= MET
Q4 2024	Nov 8, 2024	$-0.00	$-0.02	-474.7%	✗ MISS
Q3 2024	Aug 8, 2024	$-0.01	$-0.16	-1500.0%	✗ MISS
Q2 2024	May 15, 2024	$-0.02	$-0.02	-4.8%	✗ MISS
Q1 2024	Mar 15, 2024	$-0.02	$0.01	+150.0%	✓ BEAT
Q4 2023	Nov 15, 2023	$-0.04	$-0.04	0.0%	= MET
Q3 2023	Aug 16, 2023	$-0.04	$-0.05	-25.0%	✗ MISS
Q2 2023	May 24, 2023	$-0.06	$-0.09	-50.0%	✗ MISS
Q1 2023	Mar 21, 2023	$-0.01	$-0.03	-118.8%	✗ MISS
Q4 2022	Nov 15, 2022	$-0.01	$-0.03	-256.3%	✗ MISS
Q3 2022	Aug 18, 2022	$-0.01	$-0.05	-558.8%	✗ MISS
Q2 2022	May 18, 2022	$-0.01	$-0.09	-1280.4%	✗ MISS
Q1 2022	Mar 25, 2022	$0.02	$0.01	-41.6%	✗ MISS
Q4 2021	Nov 11, 2021	$0.01	$0.07	+975.3%	✓ BEAT
Q3 2021	Aug 13, 2021	—	$-0.02	—	—

Frequently Asked Questions about CRLBF

What is CRLBF's current stock price?

Cresco Labs Inc. (CRLBF) is currently trading at $1.30 per share. The stock has moved +8.33% today.

What is the analyst price target for CRLBF?

The average analyst price target for CRLBF is $5.50, based on 1 analyst.

What sector is Cresco Labs Inc. in?

Cresco Labs Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CRLBF's market cap?

Cresco Labs Inc. has a market capitalization of $0.44 billion, making it a small-cap company.

Does CRLBF pay dividends?

No, Cresco Labs Inc. does not currently pay a dividend to shareholders.